Explore Rankings
Journal profile · Computer Science

Expert Opinion on Drug Discovery

Taylor & Francis · United Kingdom · ISSN 1746-0441, 1746-045X

ITS Journal Score81.3
Global rank#1,724
Rank in Computer Science#98 of 3,238
h-index113
Open access 2021–202537%

Overview

Expert Opinion on Drug Discovery, published by Taylor & Francis (United Kingdom), published 514 papers in 2021–2025, and its papers received 10,141 citations in those years. Its h-index is 113 and its two-year mean citedness is 6.97. On the ITS Journal Score it ranks #1,724 of 62,158 ranked journals and #98 of 3,238 in Computer Science.

Key figures

Papers 2021–2025514
Citations 2021–202510,141
Citations per paper19.7
h-index113
i10-index1,438
2-year mean citedness6.97
Open-access share37%
Change in papers, 2020→2025-24%
Article fee (APC)Not recorded

Citations count every citation the journal's papers received in these years, including citations to older papers. Two-year mean citedness is OpenAlex's measure of how often recent papers are cited; it is similar in idea to, but not the same as, an impact factor.

Papers and citations by year

YearPapersCitations receivedOpen-access papers
20201454,95454
2021903,87736
20221012,24037
20231182,12642
2024951,35339
202511054534

What it publishes

The leading research topics of its papers (OpenAlex topic classification). Select a topic to find other journals that publish on it.

Similar journals

Ranked journals that publish on the same topics.

JournalFieldScorePapers 2021–2025Open access
SAR and QSAR in environmental researchComputer Science68.725719%
Current Computer - Aided Drug DesignComputer Science62.630611%
Journal of CheminformaticsComputer Science83.4658100%
Molecular InformaticsComputer Science70.634351%
Journal of Chemical Information and ModelingComputer Science85.83,88153%
Drug Discovery TodayComputer Science88.41,40541%
Computational ToxicologyComputer Science67.023546%
Journal of Computer-Aided Molecular DesignComputer Science70.237541%

Compare with similar journals (side by side with the two closest journals above)

Identity and sources

  • ISSN-L: 1746-0441
  • Print ISSN: 1746-0441
  • Electronic ISSN: 1746-045X
  • Publisher: Taylor & Francis
  • Listed in DOAJ: Not yet checked
  • Crossref: ISSN found in Crossref
  • OpenAlex: S142541038
  • Journal website: www.tandfonline.com

Figures come from OpenAlex (papers, citations, h-index, topics), Crossref (ISSN check) and DOAJ (open-access listing and fees). They change as records are corrected, so treat them as a dated snapshot. This page does not state whether the journal is indexed in Scopus, Web of Science or PubMed.

Questions

What is the ITS Journal Score of Expert Opinion on Drug Discovery?

It is 81.3 out of 100, which places it #1,724 among ranked journals. The score combines citation impact (45%), h-index (35%) and size (20%) from open OpenAlex data.

What is the impact factor of Expert Opinion on Drug Discovery?

This site does not publish Journal Impact Factors, which belong to Clarivate. As an open alternative, its two-year mean citedness in OpenAlex is 6.97.

Is Expert Opinion on Drug Discovery open access?

37% of its papers from 2021–2025 are recorded as open access.

Does Expert Opinion on Drug Discovery charge a publication fee?

No fee is recorded in the open data used here. Check the journal's own website for its current fees.

Transparent methodology

How the ITS Journal Score works

One formula applies to every ranked journal, using open data from OpenAlex: 45% citation impact, 35% h-index and 20% size (papers published 2021–2025). Citation impact is the smaller of the journal's two-year mean citedness and its five-year citations per paper, so a journal whose output collapsed cannot jump to the top on old citations. Each part is half a percentile and half a log-scaled value, so the very top is still separated. Growth and open-access share are shown separately and are not part of the score.

A journal is ranked only if it published at least 50 papers in 2021–2025 and was active in at least five of the last six years. Field rankings compare a journal only with journals in the same field; the field is the OpenAlex field with most of the journal's recent papers, or "Multidisciplinary" when no field has 30% of them.

What this is not: the ITS Journal Score is not a Journal Impact Factor, CiteScore or SJR, and this site does not say whether a journal is indexed in Scopus, Web of Science or PubMed. Always confirm aims and scope, indexing, peer review and fees on the journal's own website before you submit.